Structure-activity relationships in platelet activating factor. 9. From PAF-antagonism to PLA2 inhibition.
Many important mediators of inflammation result from the liberation of free arachidonic acid from phospholipid pools, which arise from the action of phospholipase A2 (PLA2). Therefore the inhibition of this enzyme would be an important treatment in many inflammatory disease states. Starting from a series of compounds which are known as PAF-antagonists, we have synthesized new molecules. These new compounds inhibited various secretory PLA2s, with IC50's in the mumol range. This allowed us to analyze the structure-activity relationships for PLA2 inhibition. The results showed that inhibition of secretory PLA2 depends on the length of the alkyl chain, with an optimum for 13 to 17 carbons, which is in agreement with X-ray crystallographic and nuclear magnetic resonance (NMR) studies on the active site of PLA2s, and that a free nitrogen on the piperazine ring is required to ensure a good inhibitory potency.
Binisti
C
C
Université Paris 7-Denis Diderot, Unité de Recherches Chimie et Pharmacologie, Paris, France.
Touboul
E
E
Mounier
C
C
Heymans
F
F
Bon
C
C
Godfroid
J J
JJ
D000818:Animals; D001665:Binding Sites; D001792:Blood Platelets / Q000201:enzymology; D002417:Cattle; D004791:Enzyme Inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology; D015394:Molecular Structure; D010179:Pancreas / Q000201:enzymology; D010741:Phospholipases A / Q000037:antagonists & inhibitors* / Q000737:chemistry; D054467:Phospholipases A2; D010879:Piperazines / Q000138:chemical synthesis / Q000494:pharmacology; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors* / Q000737:chemistry* / Q000502:physiology; D011817:Rabbits; D013329:Structure-Activity Relationship
D004791:Enzyme Inhibitors; D010879:Piperazines; D010972:Platelet Activating Factor; D010741:Phospholipases A; D054467:Phospholipases A2